Retroperitoneale Residualtumorresektion nach Chemotherapie maligner Hodentumoren

• Literatur

• 1 Albers P, Albrecht W, Algaba F. et al. European Association of Urology. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60: 304-319
• 2 Albers P, Weissbach L, Krege S. et al. German Testicular Cancer Study Group . Prediction of necrosis after chemotherapy of advanced germ cell tumors: Results of a prospective multicenter trial of the German Testicular Cancer Study Group. J Urol 2004; 171: 1835-1838
• 3 Albers P, Ganz A, Hannig E. et al. Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 2000; 164: 381-384
• 4 Bachner M, Loriot Y, Gross-Goupil M. et al. 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: A retrospective validation of the SEMPET trial Ann Oncol 2012; 23: 59-64
• 5 Ehrlich Y, Brames MJ, Beck SD. et al. Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: Is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?. J Clin Oncol 2010; 28: 531-536
• 6 Fizazi K, Tjulandin S, Salvioni R. et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group. J Clin Oncol 2001; 15: 2647-2657
• 7 Kollmannsberger C, Daneshmand S, So A. et al. Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery. J Clin Oncol 2010; 28: 537-542
• 8 Krege S, Beyer J, Souchon R. et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II. Eur Urol 2008; 53: 497-513
• 9 Wahle GR, Foster RS, Bihrle R. et al. Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma. J Urol 1994; 152: 428-430
• 10 Winter C, Pfister D, Busch J. et al. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: A multicenter analysis of the German Testicular Cancer Study Group. Eur Urol 2012; 61: 403-409
• 11 Winter C, Albers P. Testicular germ cell tumors: Pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 2011; 7: 43-53